Aprea Therapeutics

Home » Aprea Therapeutics

IPO

Aprea Therapeutics

Biopharmaceutical

We are a clinical-stage biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein.

Symbol

APRE

Price Range
$14.00 - $16.00

Final Shares
5,000,000

Anticipated Date
October 3, 2019

Underwriters
J.P. MORGAN SECURITIES LLC,MORGAN STANLEY & CO. LLC

To view the prospectus for Aprea Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253